MicroRNA-126 Overexpression Inhibits Proliferation and Invasion in Osteosarcoma Cells

Shuaihua Wang1, Xinlei Wang2, Qiang Guo3

  • 1Department of Pediatric Orthopedics and Bone Oncology, Linyi People's Hospital Affiliated to Shandong University, Linyi, Lanshan, Shandong, P.R. China.

Insights

MicroRNA-126 overexpression inhibits proliferation, migration, and invasion in human osteosarcoma cells. This effect is mediated by targeting ADAM9, a key regulator of these cellular processes.

Area of Science:

  • Molecular Biology
  • Oncology
  • Biochemistry

Background:

  • Osteosarcoma is a primary malignant bone tumor with a high risk of metastasis.
  • MicroRNAs (miRNAs) are small non-coding RNAs that regulate gene expression and play crucial roles in various biological processes, including cancer development.
  • Dysregulation of miRNA expression is implicated in the pathogenesis of many cancers, including osteosarcoma.

Purpose of the Study:

  • To investigate the biological effects of microRNA-126 (miR-126) overexpression in human MG63 osteosarcoma cells.
  • To determine the impact of miR-126 on cell proliferation, cell cycle, migration, and invasion.
  • To elucidate the underlying molecular mechanism, specifically the role of ADAM9 as a potential target of miR-126.

Main Methods:

  • Construction and transfection of a recombinant plasmid (pcDNA6.2-microRNA-126) into MG63 cells.
  • Quantification of miR-126 expression using real-time quantitative polymerase chain reaction.
  • Assessment of cell proliferation (MTT assay), cell cycle distribution (flow cytometry), cell migration (wound-healing assay), and invasion (Transwell assay).
  • Analysis of ADAM9 expression levels.

Main Results:

  • miR-126 expression was significantly upregulated in transfected MG63 cells.
  • Overexpression of miR-126 led to a significant reduction in cell proliferation, migration, and invasion.
  • miR-126 induced G0/G1 cell cycle arrest and decreased the proliferation index.
  • ADAM9 expression was significantly reduced in cells overexpressing miR-126, indicating ADAM9 is a direct target.
  • Restoring ADAM9 expression partially reversed the inhibitory effects of miR-126 on cell proliferation, migration, and invasion.

Conclusions:

  • MicroRNA-126 acts as a tumor suppressor in human osteosarcoma cells.
  • miR-126 inhibits cell proliferation, migration, and invasion by targeting ADAM9.
  • These findings highlight the potential of miR-126 as a therapeutic target for osteosarcoma.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.3K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.7K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K